Developer docs
API playgroundTry for free, no card

Search company profiles

Kayentis

Full company profile

uuid0002lf7

Namestring
Kayentis
Legal namestring
KAYENTIS SAS
Websiteurl
kayentis.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Kayentis SAS is a privately held French clinical technology company founded in 2005 and headquartered in Meylan, France, with a US regional office in Boston. The company operates as a B2B enterprise solution provider serving pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs) conducting clinical trials globally. Its core offering is the Clin'form electronic Clinical Outcome Assessment (eCOA) platform, which captures Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO data across home and on-site settings, supported by modular add-ons including Televisit, Patient Engagement Modules, WebCOA back-up, and external system interoperability with IRT, patient portals, and clinical data lakes.

The platform is extended by a suite of services spanning COA strategy advisory, project management, data management, and worldwide logistics with 24/7 multilingual helpdesk support. In June 2026, Kayentis launched an AI-enabled Interactive eConsent module that uses generative AI and knowledge retrieval to transform lengthy paper consent forms into multimedia guided experiences incorporating video, interactive glossary, and comprehension questions, with 21 CFR Part 11 compliance. The company has supported more than 400 clinical trials across 90+ countries, all clinical phases (I-IV), 20+ therapeutic areas, and over 200 indications.

Kayentis operates an enterprise field sales model with custom quote-based pricing tied to study complexity, geographic scope, and service requirements, typically structured as multi-year subscription contracts. The company reports a 95.9% client recommendation rate and an NPS of +72. Recent strategic actions include a March 2026 strategic alliance with Perceptive eClinical to deliver an integrated eCOA-IRT solution and ongoing product expansion into AI-enabled patient engagement workflows. The company is structured as a Société par Actions Simplifiée (SAS) with share capital of €2,522,119.70 and no identified parent company or external private equity sponsor.

Short descriptiontext

Kayentis is a French clinical technology company providing the Clin'form eCOA platform and related services to pharmaceutical, biotechnology, and CRO clients, supporting electronic clinical outcome assessments across 400+ trials in 90+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMeylan, France
HQ citystring
Meylan
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
electronic clinical outcome assessment, decentralized clinical trials, patient reported outcomes software, clinical trial data capture, eCOA platform solutions
Industry2 codes
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Other Ambulatory Health Care Services6219
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
Product category
Electronic Clinical Outcome Assessment (eCOA) Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1eCOA Platform Licensing and Services
TypeSubscription Recurring
Description

Kayentis provides its Clin'form eCOA platform and related services to pharmaceutical sponsors and CROs conducting clinical trials. The revenue model involves licensing the platform along with comprehensive services including COA strategy advisory, project management, data management, and worldwide logistics support. Services are provided throughout the clinical trial lifecycle from early strategic engagement through database lock.

kayentis.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1Enterprise custom pricing based on study requirements
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Pricing varies based on study complexity, number of questionnaires, therapeutic areas, geographic scope, and service requirements. No public pricing tiers available.

kayentis.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Clin'form
Description

The primary eCOA (Electronic Clinical Outcome Assessment) platform developed by Kayentis for capturing patient data in clinical trials, supporting PRO, Diaries, ObsRO, and ClinRO questionnaires with capabilities for televisit, patient engagement modules, and connection with external systems like IRT.

kayentis.com
Core offering1 text field

Kayentis provides the Clin'form electronic Clinical Outcome Assessment (eCOA) platform that captures Patient-Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires during clinical trials, either at home or on-site, across all phases (I-IV) and therapeutic areas. The platform is sold with bundled first-class services including COA strategy advisory, project management, data management, worldwide device logistics, and a 24/7 multilingual helpdesk. Modular add-ons extend the platform with embedded Televisit, patient engagement features, external system interoperability (IRT, clinical data lakes, patient portals), an AI-enabled Interactive eConsent solution, and a WebCOA Back-up.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 89% of sites are very satisfied or satisfied with the Clin'form solution
+4 more records
Product overview1 text field

Kayentis offers a unified platform-plus-modules architecture centered on the Clin'form eCOA platform — a comprehensive electronic Clinical Outcome Assessment solution that collects PRO, Diary, ObsRO, and ClinRO data at home or on-site. This core platform is extended by modular add-ons including Televisit (embedded telemedicine), Patient Engagement Modules, Connection with External Systems (IRT, patient portal, clinical data lake interoperability), and the newly launched Interactive eConsent Solution (AI-enabled multimedia consent module). The platform is complemented by a suite of first-class services: COA Strategy Advisory Support, Project Management and Governance, Data Management, and Worldwide Logistics with 24/7 Helpdesk. Kayentis supports clinical trials across 20+ therapeutic areas, over 200 indications, and all clinical phases (I–IV) in over 90 countries.

Product and service10 records
1Clin'form eCOA Platform
CategoryElectronic Clinical Outcome Assessment Software
Description

Kayentis's flagship electronic Clinical Outcome Assessment (eCOA) platform enabling electronic collection of Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires at home or on-site, supporting all levels of trial complexity across global clinical studies. Sold to pharmaceutical sponsors, biotechs, and CROs conducting Phase I-IV trials.

2Televisit Module
CategoryDecentralized Clinical Trial Module
Description

Embedded telemedicine module within the Clin'form eCOA app enabling planned and unplanned televisit sessions between study participants and clinical site personnel, supporting remote consultations during clinical trials.

3Patient Engagement Modules
CategoryPatient Engagement Software Module
Description

Collection of patient engagement features within Clin'form eCOA designed to ensure high patient compliance, including a patient resources library, Participant Feedback Questionnaire (PFQ), and goal-oriented gamification elements for pediatric populations.

4Connection with External Systems (IRT, Patient Portal, Clinical Data Lake)
CategorySystem Interoperability Module
Description

Interoperability module within Clin'form enabling connection with IRT systems, patient portals, and clinical data lakes, providing a unified access point for patients and sites and streamlining end-to-end clinical data flow.

5Interactive eConsent Solution
CategoryElectronic Informed Consent (eConsent) Software
Description

AI-enabled electronic informed consent module embedded within the Clin'form eCOA platform that transforms complex paper consent forms into simplified, multimedia guided digital experiences with video, interactive glossary, comprehension questions, and 21 CFR Part 11 compliant electronic signatures for on-site, remote, and hybrid consent models.

6WebCOA Back-up
CategoryContingency eCOA Capture Module
Description

Web-based back-up solution for eCOA studies enabling patients to complete questionnaires via any browser when the primary device-based solution is unavailable, ensuring continuous digital data collection without paper reliance.

7COA Strategy Advisory Support
CategoryClinical Consulting Service
Description

Early consulting service provided by Kayentis's scientific and medical experts to help sponsors design a relevant clinical outcome assessment (COA) strategy aligned with regulatory expectations and patient needs.

8Project Management and Governance
CategoryClinical Trial Operations Service
Description

Dedicated project management services ensuring smooth clinical trial execution and alignment with sponsor standards throughout the study lifecycle.

9Data Management
CategoryClinical Data Management Service
Description

Comprehensive data management services including edit checks, query management, data quality control, audit trails, and robust data analytics to ensure high-quality datasets from the start of each study.

10Worldwide Logistics and 24/7 Helpdesk
CategoryGlobal Logistics and Support Service
Description

Global logistics management for device provisioning and a 24/7 multilingual helpdesk providing round-the-clock support to study participants and clinical site staff across all geographies.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-24
Description

Perceptive eClinical and Kayentis formed a strategic alliance to deliver a fully integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The combined platform streamlines workflows, improves data quality, and simplifies study setup by combining Perceptive's Interactive Response Technology expertise with Kayentis' eCOA capabilities. Both companies view this as beginning of broader interoperability expansion across the clinical trial lifecycle.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medidata offers the Rave eCOA module as part of its broader EDC/CTMS suite, directly competing with Kayentis's Clin'form in the same pharma/biotech/CRO buyer base. As the market-leading eClinical platform, it sets the benchmark for integrated, end-to-end trial technology that Kayentis must differentiate against.

TypeBroad incumbent
Description

Veeva's Vault eCOA and Vault Clinical Suite serve the same enterprise pharma customer base as Kayentis, with deep CRM, CTMS, and EDC adjacency. It is a key competitor for full-suite enterprise deals where sponsors prefer a single-vendor stack.

TypeBroad incumbent
Description

Oracle Clinical One (formerly Phase One) provides eCOA alongside EDC, RTSM, and analytics in a unified platform, targeting the same pharma/biotech sponsors. It is one of the most direct platform-suite competitors to Kayentis's specialist eCOA offering.

TypeDirect peer
Description

Clario (formed from the merger of ERT and CRF Health) is a direct eCOA specialist competitor with deep therapeutic-area expertise and global trial support, serving the same pharma/CRO customers. It is among the most comparable scale specialists in eCOA.

TypeDirect peer
Description

Signant Health provides eCOA, eConsent, and rater training solutions for clinical trials, overlapping heavily with Kayentis's product portfolio. It competes for the same CNS, rare disease, and patient-centric trials where Kayentis has stated expertise.

TypeDirect peer
Description

YPrime offers eCOA, IRT, and clinical supply chain solutions for pharma and CROs, with comparable mid-tier positioning to Kayentis. It is a direct competitor for studies requiring integrated eCOA+IRT functionality.

TypeEmerging player
Description

Castor provides eCOA, EDC, and DCT solutions with a modern, API-first platform targeting the same pharma/biotech segment. It competes with Kayentis for digitally native sponsors and DCT-focused studies, though at a smaller scale.

TypeDirect peer
Description

Medrio offers eCOA and eClinical solutions for clinical research, with particular strength in early-phase trials. It competes with Kayentis across phases I–IV and overlaps on therapeutic area breadth and CRO relationships.

TypeEmerging player
Description

ObvioHealth is a DCT-native eCOA/virtual trial platform focused on patient-centric trial delivery. It competes with Kayentis in the DCT segment where Kayentis also markets televisit, BYOD, and remote data collection capabilities.

TypeOthers
Description

Perceptive eClinical is Kayentis's strategic alliance partner for IRT integration, addressing the joint problem of system fragmentation in clinical trials. While not a direct competitor in eCOA, it is a critical ecosystem participant whose relationship direction affects Kayentis's go-to-market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kayentis

Electronic Clinical Outcome Assessment (eCOA) Softwarekayentis.com

Kayentis is a French clinical technology company providing the Clin'form eCOA platform and related services to pharmaceutical, biotechnology, and CRO clients, supporting electronic clinical outcome assessments across 400+ trials in 90+ countries.

What Kayentis does

Kayentis SAS is a privately held French clinical technology company founded in 2005 and headquartered in Meylan, France, with a US regional office in Boston. The company operates as a B2B enterprise solution provider serving pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs) conducting clinical trials globally. Its core offering is the Clin'form electronic Clinical Outcome Assessment (eCOA) platform, which captures Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO data across home and on-site settings, supported by modular add-ons including Televisit, Patient Engagement Modules, WebCOA back-up, and external system interoperability with IRT, patient portals, and clinical data lakes.

The platform is extended by a suite of services spanning COA strategy advisory, project management, data management, and worldwide logistics with 24/7 multilingual helpdesk support. In June 2026, Kayentis launched an AI-enabled Interactive eConsent module that uses generative AI and knowledge retrieval to transform lengthy paper consent forms into multimedia guided experiences incorporating video, interactive glossary, and comprehension questions, with 21 CFR Part 11 compliance. The company has supported more than 400 clinical trials across 90+ countries, all clinical phases (I-IV), 20+ therapeutic areas, and over 200 indications.

Kayentis operates an enterprise field sales model with custom quote-based pricing tied to study complexity, geographic scope, and service requirements, typically structured as multi-year subscription contracts. The company reports a 95.9% client recommendation rate and an NPS of +72. Recent strategic actions include a March 2026 strategic alliance with Perceptive eClinical to deliver an integrated eCOA-IRT solution and ongoing product expansion into AI-enabled patient engagement workflows. The company is structured as a Société par Actions Simplifiée (SAS) with share capital of €2,522,119.70 and no identified parent company or external private equity sponsor.

Kayentis firmographics

Firmographics
Name
Kayentis
Legal name
KAYENTIS SAS
Website
https://kayentis.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
Kayentis is a French clinical technology company providing the Clin'form eCOA platform and related services to pharmaceutical, biotechnology, and CRO clients, supporting electronic clinical outcome assessments across 400+ trials in 90+ countries.
Ownership category
akta.pro rank

Kayentis industry classification

Industry
Product category
Electronic Clinical Outcome Assessment (eCOA) Software
NAICS
Computer Systems Design and Related Services (54151), Other Ambulatory Health Care Services (6219)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLACAOAB
eCOA/ePRO/eDiary & Patient-Facing Data Collection
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACAFAO
Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Electronic clinical outcome assessment
  • Decentralized clinical trials
  • Patient reported outcomes software
  • Clinical trial data capture
  • ECOA platform solutions

Where Kayentis is headquartered

Location

Headquarters

HQ city
Meylan
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Kayentis business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. eCOA Platform Licensing and Services: Kayentis provides its Clin'form eCOA platform and related services to pharmaceutical sponsors and CROs conducting clinical trials. The revenue model involves licensing the platform along with comprehensive services including COA strategy advisory, project management, data management, and worldwide logistics support. Services are provided throughout the clinical trial lifecycle from early strategic engagement through database lock.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise custom pricing based on study requirements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Kayentis product offering

Product offering

Core offering

Kayentis provides the Clin'form electronic Clinical Outcome Assessment (eCOA) platform that captures Patient-Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires during clinical trials, either at home or on-site, across all phases (I-IV) and therapeutic areas. The platform is sold with bundled first-class services including COA strategy advisory, project management, data management, worldwide device logistics, and a 24/7 multilingual helpdesk. Modular add-ons extend the platform with embedded Televisit, patient engagement features, external system interoperability (IRT, clinical data lakes, patient portals), an AI-enabled Interactive eConsent solution, and a WebCOA Back-up.

Product overview

Kayentis offers a unified platform-plus-modules architecture centered on the Clin'form eCOA platform — a comprehensive electronic Clinical Outcome Assessment solution that collects PRO, Diary, ObsRO, and ClinRO data at home or on-site. This core platform is extended by modular add-ons including Televisit (embedded telemedicine), Patient Engagement Modules, Connection with External Systems (IRT, patient portal, clinical data lake interoperability), and the newly launched Interactive eConsent Solution (AI-enabled multimedia consent module). The platform is complemented by a suite of first-class services: COA Strategy Advisory Support, Project Management and Governance, Data Management, and Worldwide Logistics with 24/7 Helpdesk. Kayentis supports clinical trials across 20+ therapeutic areas, over 200 indications, and all clinical phases (I–IV) in over 90 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Clin'form: The primary eCOA (Electronic Clinical Outcome Assessment) platform developed by Kayentis for capturing patient data in clinical trials, supporting PRO, Diaries, ObsRO, and ClinRO questionnaires with capabilities for televisit, patient engagement modules, and connection with external systems like IRT.

Products and services

  • Clin'form eCOA Platform Kayentis's flagship electronic Clinical Outcome Assessment (eCOA) platform enabling electronic collection of Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires at home or on-site, supporting all levels of trial complexity across global clinical studies. Sold to pharmaceutical sponsors, biotechs, and CROs conducting Phase I-IV trials.
  • Televisit Module Embedded telemedicine module within the Clin'form eCOA app enabling planned and unplanned televisit sessions between study participants and clinical site personnel, supporting remote consultations during clinical trials.
  • Patient Engagement Modules Collection of patient engagement features within Clin'form eCOA designed to ensure high patient compliance, including a patient resources library, Participant Feedback Questionnaire (PFQ), and goal-oriented gamification elements for pediatric populations.
  • Connection with External Systems (IRT, Patient Portal, Clinical Data Lake) Interoperability module within Clin'form enabling connection with IRT systems, patient portals, and clinical data lakes, providing a unified access point for patients and sites and streamlining end-to-end clinical data flow.
  • Interactive eConsent Solution AI-enabled electronic informed consent module embedded within the Clin'form eCOA platform that transforms complex paper consent forms into simplified, multimedia guided digital experiences with video, interactive glossary, comprehension questions, and 21 CFR Part 11 compliant electronic signatures for on-site, remote, and hybrid consent models.
  • WebCOA Back-up Web-based back-up solution for eCOA studies enabling patients to complete questionnaires via any browser when the primary device-based solution is unavailable, ensuring continuous digital data collection without paper reliance.
  • COA Strategy Advisory Support Early consulting service provided by Kayentis's scientific and medical experts to help sponsors design a relevant clinical outcome assessment (COA) strategy aligned with regulatory expectations and patient needs.
  • Project Management and Governance Dedicated project management services ensuring smooth clinical trial execution and alignment with sponsor standards throughout the study lifecycle.
  • Data Management Comprehensive data management services including edit checks, query management, data quality control, audit trails, and robust data analytics to ensure high-quality datasets from the start of each study.
  • Worldwide Logistics and 24/7 Helpdesk Global logistics management for device provisioning and a 24/7 multilingual helpdesk providing round-the-clock support to study participants and clinical site staff across all geographies.

Quantifiable outcome

  • 89% of sites are very satisfied or satisfied with the Clin'form solution
  • +4 more outcomes

Companies that use Kayentis

Customer profile

Segments3 records

Ideal customer profiles3 records

Kayentis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability5 records

Feature7 records

Kayentis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Perceptive eClinicalcoreStrategic or Co-development Partner · 24 March 2026Perceptive eClinical and Kayentis formed a strategic alliance to deliver a fully integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The combined platform streamlines workflows, improves data quality, and simplifies study setup by combining Perceptive's Interactive Response Technology expertise with Kayentis' eCOA capabilities. Both companies view this as beginning of broader interoperability expansion across the clinical trial lifecycle.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Kayentis competitors and assessment

Company assessment

Broad incumbents

  • Medidata Solutions (Dassault Systèmes): Medidata offers the Rave eCOA module as part of its broader EDC/CTMS suite, directly competing with Kayentis's Clin'form in the same pharma/biotech/CRO buyer base. As the market-leading eClinical platform, it sets the benchmark for integrated, end-to-end trial technology that Kayentis must differentiate against.
  • Veeva Systems: Veeva's Vault eCOA and Vault Clinical Suite serve the same enterprise pharma customer base as Kayentis, with deep CRM, CTMS, and EDC adjacency. It is a key competitor for full-suite enterprise deals where sponsors prefer a single-vendor stack.
  • Oracle Clinical One: Oracle Clinical One (formerly Phase One) provides eCOA alongside EDC, RTSM, and analytics in a unified platform, targeting the same pharma/biotech sponsors. It is one of the most direct platform-suite competitors to Kayentis's specialist eCOA offering.

Direct peers

  • Clario: Clario (formed from the merger of ERT and CRF Health) is a direct eCOA specialist competitor with deep therapeutic-area expertise and global trial support, serving the same pharma/CRO customers. It is among the most comparable scale specialists in eCOA.
  • Signant Health: Signant Health provides eCOA, eConsent, and rater training solutions for clinical trials, overlapping heavily with Kayentis's product portfolio. It competes for the same CNS, rare disease, and patient-centric trials where Kayentis has stated expertise.
  • YPrime: YPrime offers eCOA, IRT, and clinical supply chain solutions for pharma and CROs, with comparable mid-tier positioning to Kayentis. It is a direct competitor for studies requiring integrated eCOA+IRT functionality.
  • Medrio: Medrio offers eCOA and eClinical solutions for clinical research, with particular strength in early-phase trials. It competes with Kayentis across phases I–IV and overlaps on therapeutic area breadth and CRO relationships.

Emerging players

  • Castor: Castor provides eCOA, EDC, and DCT solutions with a modern, API-first platform targeting the same pharma/biotech segment. It competes with Kayentis for digitally native sponsors and DCT-focused studies, though at a smaller scale.
  • ObvioHealth: ObvioHealth is a DCT-native eCOA/virtual trial platform focused on patient-centric trial delivery. It competes with Kayentis in the DCT segment where Kayentis also markets televisit, BYOD, and remote data collection capabilities.

Others

  • Perceptive eClinical: Perceptive eClinical is Kayentis's strategic alliance partner for IRT integration, addressing the joint problem of system fragmentation in clinical trials. While not a direct competitor in eCOA, it is a critical ecosystem participant whose relationship direction affects Kayentis's go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Kayentis social profiles

Digital presence

Kayentis compliance and trust

Trust signal

Compliance2 records

Kayentis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kayentis leadership team

Management profile

Number of profiles

Profiles6 records

Kayentis funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kayentis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kayentis

What does Kayentis do?

Kayentis provides the Clin'form electronic Clinical Outcome Assessment (eCOA) platform that captures Patient-Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires during clinical trials, either at home or on-site, across all phases (I-IV) and therapeutic areas. The platform is sold with bundled first-class services including COA strategy advisory, project management, data management, worldwide device logistics, and a 24/7 multilingual helpdesk. Modular add-ons extend the platform with embedded Televisit, patient engagement features, external system interoperability (IRT, clinical data lakes, patient portals), an AI-enabled Interactive eConsent solution, and a WebCOA Back-up.

Is Kayentis a public or private company?

Kayentis is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kayentis founded?

Kayentis was founded in 2005. It employs 101 to 250 people.

Where is Kayentis based?

Kayentis is headquartered in Meylan, France, in the Europe region.

How does Kayentis make money?

One revenue line is on record: eCOA Platform Licensing and Services.

Who are Kayentis's main competitors?

Broad incumbents on record are Medidata Solutions (Dassault Systèmes), Veeva Systems and Oracle Clinical One. Direct peers are Clario, Signant Health, YPrime and Medrio. Emerging players are Castor and ObvioHealth. Perceptive eClinical is listed as an others.

Does Kayentis have an API?

No public API is recorded for Kayentis.

What industry is Kayentis in?

Kayentis's product category is Electronic Clinical Outcome Assessment (eCOA) Software. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmafileKayentis and RWS partner to improve clinical trial data confidenceKayentis and RWS announced a partnership to improve confidence in clinical trial data for neuroscience and complex trials. The collaboration combines Kayentis' eCOA platform with RWS' rater training services to reduce variability in clinician-reported outcomes. The solution is available for sponsors and CROs managing CNS and other complex trials.Business Wire BlogPerceptive eClinical and Kayentis Partner to Deliver Integrated eCOA–IRT Solution That Reduces Digital System Complexity in Global Clinical TrialsPerceptive eClinical and Kayentis have announced a strategic partnership to deliver an integrated eCOA-IRT solution for global clinical trials, combining electronic Clinical Outcome Assessment and Interactive Response Technology platforms. The integrated offering addresses the operational burden of fragmented digital ecosystems by enabling unified user access, automatic patient data transfer, and automated workflow triggers between the two systems. Both companies are committed to expanding interoperability over time with a shared roadmap for deeper integration across the clinical technology ecosystem.YahooPerceptive eClinical and Kayentis Partner to Deliver Integrated eCOA–IRT Solution That Reduces Digital System Complexity in Global Clinical TrialsPerceptive eClinical and Kayentis announced a strategic partnership to deliver an integrated eCOA–IRT solution for clinical trials, aiming to reduce digital system complexity and operational burdens. The joint platform streamlines workflows, improves data quality, and simplifies study setup, offering benefits throughout the trial lifecycle.PharmiWeb.comPerceptive eClinical and Kayentis partner to tackle increasing digital system complexity in global clinical trialsPerceptive eClinical and Kayentis announced a strategic alliance to deliver a fully integrated eCOA-IRT solution for clinical trials, addressing the industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The partnership combines Perceptive eClinical's Interactive Response Technology expertise with Kayentis' electronic Clinical Outcome Assessment capabilities to streamline trial execution, reduce site workload, and lower study costs through automatic data transfer and workflow integration. Both companies view this collaboration as the beginning of broader interoperability expansion across the clinical trial lifecycle.KayentisKayentis raises further €5M to boost US activitiesKayentis has secured an additional €5 million in financing to enhance its operations in North America, aiming to support clinical trials more effectively. The new funds comprise €2.2 million from existing investors LBO France, Extens, and Bpifrance, alongside €2.8 million in bank loans. This expansion is intended to increase Kayentis' capacity in digital data collection and decentralized clinical trial solutions.FinSMEsKayentis Raises Further €5M in FundingKayentis, a Grenoble-based provider of electronic Clinical Outcome Assessment and Decentralized Clinical Trial solutions, raised an additional €5M in funding to scale up its operations in North America. The funding round was led by LBO France, Extens, and Bpifrance, who contributed €2.2M, while Kayentis secured an additional €2.8M through bank loans. The company aims to support clinical trials with improved efficiency and quality through its services.FierceBiotechClinOne and Kayentis in pact to address DCT, hybrid trial needsClinOne and Kayentis announced a partnership to address decentralized and hybrid clinical trial needs, combining ClinOne's adaptive trial experience with Kayentis' clinical outcome assessment and DCT solutions. The collaboration will build a web portal, integrated device solution, and account management system, with globalData estimating 1,300 DCT or virtual trials in 2022, a 28% increase from 2021.KayentisKayentis launches fully integrated platform for decentralized clinical trialsKayentis, a French provider of eCOA and decentralized clinical trial solutions, announced on March 23, 2022 a fully integrated, patient-centric platform for hybrid and decentralized trials. The platform combines data collection modes including BYOD, webCOA, provisioned devices and phone entry, plus a telemedicine app, single sign-on and a participant feedback module. The company has collected data for over 260 trials in 79 countries.FinSMEsKayentis Raises €7M in FundingKayentis, a clinical trial data capture provider, raised €7M in growth funding led by Extens and LBO France with Bpifrance participation. The funds will accelerate R&D for its Clin'form3 eCOA platform and expand US operations. The company has collected data for over 220 trials across 79 countries.